Drug sales outweighed pandemic impact on Janssen Denmark's 2021 report
Despite facing several problems throughout 2021, including a national nurse strike, Janssen’s subsidiary in Denmark managed to book its best ever year.
.jpg)
by mikkel aabenhus hemmingsen, translated by daniel pedersen
2021 was a record year for Janssen’s division in Denmark, whose revenue and bottom line reached unprecedented heights, according to the firm’s financial report for the full year.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Janssen's sales of Darzalex exceed expectations
For subscribers
New arbitration full of upsides for Genmab, says analyst
For subscribers
.jpg)
.jpg&w=384&q=75)
